Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback